{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:08:50Z","timestamp":1790636930935,"version":"4.1.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cancertreatmentreviews.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.ctrv.2013.06.005","type":"journal-article","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T14:02:04Z","timestamp":1373983324000},"page":"22-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Hormones of adipose tissue and their biologic role in lung cancer"],"prefix":"10.1016","volume":"40","author":[{"given":"E.","family":"Ntikoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kiagia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Boura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.N.","family":"Syrigos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6505","key":"10.1016\/j.ctrv.2013.06.005_b0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ctrv.2013.06.005_b0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1043-2760(00)00301-5","article-title":"Adipose tissue as an endocrine organ","volume":"11","author":"Ahima","year":"2000","journal-title":"Trends Endocrinol Metab"},{"issue":"15\u201316","key":"10.1016\/j.ctrv.2013.06.005_b0015","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10354-010-0781-6","article-title":"Adipokine update - new molecules, new functions","volume":"160","author":"Gelsinger","year":"2010","journal-title":"Wien Med Wochenschr"},{"issue":"9","key":"10.1016\/j.ctrv.2013.06.005_b0020","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1373\/clinchem.2004.032482","article-title":"Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin","volume":"50","author":"Meier","year":"2004","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.ctrv.2013.06.005_b0025","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1210\/jc.2002-021215","article-title":"Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism","volume":"88","author":"Pannacciulli","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ctrv.2013.06.005_b0030","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/sj.bjc.6605665","article-title":"Adipose tissue pathways involved in weight loss of cancer cachexia","volume":"102","author":"Dahlman","year":"2010","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.ctrv.2013.06.005_b0035","doi-asserted-by":"crossref","first-page":"e34710","DOI":"10.1371\/journal.pone.0034710","article-title":"Chemerin and adiponectin contribute reciprocally to metabolic syndrome","volume":"7","author":"Chu","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ctrv.2013.06.005_b0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2183\/pjab.86.131","article-title":"Establishment of a concept of visceral fat syndrome and discovery of adiponectin","volume":"86","author":"Matsuzawa","year":"2010","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"11 Suppl.","key":"10.1016\/j.ctrv.2013.06.005_b0045","doi-asserted-by":"crossref","first-page":"3451S","DOI":"10.1093\/jn\/132.11.3451S","article-title":"The underlying basis for obesity: relationship to cancer","volume":"132","author":"Bray","year":"2002","journal-title":"J Nutr"},{"issue":"12","key":"10.1016\/j.ctrv.2013.06.005_b0050","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nrc3174","article-title":"Molecular mechanisms of cancer development in obesity","volume":"11","author":"Khandekar","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"10.1016\/j.ctrv.2013.06.005_b0055","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1467-789X.2011.00917.x","article-title":"Multiple signal pathways in obesity-associated cancer","volume":"12","author":"Chen","year":"2011","journal-title":"Obes Rev"},{"issue":"3","key":"10.1016\/j.ctrv.2013.06.005_b0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.33549\/physiolres.930848","article-title":"Adipocytokines and cancer","volume":"55","author":"Housa","year":"2006","journal-title":"Physiol Res"},{"issue":"2","key":"10.1016\/j.ctrv.2013.06.005_b0065","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ijc.2910490211","article-title":"Leanness and lung-cancer risk","volume":"49","author":"Knekt","year":"1991","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.ctrv.2013.06.005_b0070","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/oxfordjournals.aje.a117681","article-title":"Association of body mass index and body fat distribution with risk of lung cancer in older women","volume":"142","author":"Drinkard","year":"1995","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.ctrv.2013.06.005_b0075","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1378\/chest.128.3.1490","article-title":"Body mass index and lung cancer: a case-control study of subjects participating in a mass-screening program","volume":"128","author":"Kanashiki","year":"2005","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ctrv.2013.06.005_b0080","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/ije\/dyq134","article-title":"Lower lung cancer mortality in obesity","volume":"40","author":"Leung","year":"2011","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.ctrv.2013.06.005_b0085","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/j.jss.2011.04.061","article-title":"Obesity and weight loss at presentation of lung cancer are associated with opposite effects on survival","volume":"170","author":"Yang","year":"2011","journal-title":"J Surg Res"},{"issue":"4","key":"10.1016\/j.ctrv.2013.06.005_b0090","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/beem.2002.0223","article-title":"Peripheral metabolic actions of leptin","volume":"16","author":"Muoio","year":"2002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ctrv.2013.06.005_b0095","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1053\/meta.2000.9519","article-title":"Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women","volume":"49","author":"Thomas","year":"2000","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.ctrv.2013.06.005_b0100","first-page":"3408","article-title":"Leptin concentrations in relation to body mass index and the tumor necrosis factor-alpha system in humans","volume":"82","author":"Mantzoros","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ctrv.2013.06.005_b0105","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.peptides.2004.02.014","article-title":"The many lives of leptin","volume":"25","author":"Banks","year":"2004","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.ctrv.2013.06.005_b0110","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1515\/JPEM.1998.11.4.483","article-title":"Leptin as a metabolic regulator during fetal and neonatal life and in childhood and adolescence","volume":"11","author":"Kiess","year":"1998","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ctrv.2013.06.005_b0115","first-page":"2849","article-title":"Serum leptin levels in normal children: relationship to age, gender, body mass index, pituitary-gonadal hormones, and pubertal stage","volume":"82","author":"Garcia-Mayor","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl. 3","key":"10.1016\/j.ctrv.2013.06.005_b0120","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1542\/peds.2007-1813F","article-title":"Link between body fat and the timing of puberty","volume":"121","author":"Kaplowitz","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.ctrv.2013.06.005_b0125","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/rp.56.1.401","article-title":"Leptin controls bone formation through a hypothalamic relay","volume":"56","author":"Karsenty","year":"2001","journal-title":"Recent Prog Horm Res"},{"issue":"1\u20133","key":"10.1016\/j.ctrv.2013.06.005_b0130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0014-5793(02)03161-7","article-title":"Role of leptin in bone growth: central player or peripheral supporter?","volume":"528","author":"Reseland","year":"2002","journal-title":"FEBS Lett"},{"issue":"4","key":"10.1016\/j.ctrv.2013.06.005_b0135","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1189\/jlb.68.4.437","article-title":"Leptin in the regulation of immunity, inflammation, and hematopoiesis","volume":"68","author":"Fantuzzi","year":"2000","journal-title":"J Leukoc Biol"},{"issue":"4","key":"10.1016\/j.ctrv.2013.06.005_b0140","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbi.2008.10.007","article-title":"Three questions about leptin and immunity","volume":"23","author":"Fantuzzi","year":"2009","journal-title":"Brain Behav Immun"},{"issue":"12","key":"10.1016\/j.ctrv.2013.06.005_b0145","first-page":"RA282","article-title":"Leptin-from a signal of adiposity to a hormonal mediator in peripheral tissues","volume":"8","author":"Baratta","year":"2002","journal-title":"Med Sci Monit"},{"issue":"1","key":"10.1016\/j.ctrv.2013.06.005_b0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1262-3636(07)70084-8","article-title":"Adipose tissue and adipokines: for better or worse","volume":"30","author":"Guerre-Millo","year":"2004","journal-title":"Diabetes Metab"},{"issue":"2","key":"10.1016\/j.ctrv.2013.06.005_b0155","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jss.2003.09.004","article-title":"Leptin is a growth factor in cancer","volume":"116","author":"Somasundar","year":"2004","journal-title":"J Surg Res"},{"issue":"7","key":"10.1016\/j.ctrv.2013.06.005_b0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1478-811X-7-27","article-title":"Leptin and adiponectin: new players in the field of tumor cell and leukocyte migration","volume":"23","author":"Lang","year":"2009","journal-title":"Cell Commun Signal"},{"issue":"1","key":"10.1016\/j.ctrv.2013.06.005_b0165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jcp.20472","article-title":"Leptin and cancer","volume":"207","author":"Garofalo","year":"2006","journal-title":"J Cell Physiol"},{"issue":"2\u20133","key":"10.1016\/j.ctrv.2013.06.005_b0170","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0014-2999(98)00884-X","article-title":"Expression of leptin receptor in lung: leptin as a growth factor","volume":"365","author":"Tsuchiya","year":"1999","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.ctrv.2013.06.005_b0175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1556-0864(15)30035-6","article-title":"Immunoinflammatory mechanisms in lung cancer development: is leptin a mediator?","volume":"2","author":"Ribeiro","year":"2007","journal-title":"J Thorac Oncol"},{"issue":"7","key":"10.1016\/j.ctrv.2013.06.005_b0180","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1055\/s-2002-33466","article-title":"A polymorphism in the leptin promoter region (-2548 G\/A) influences gene expression and adipose tissue secretion of leptin","volume":"34","author":"Hoffstedt","year":"2002","journal-title":"Horm Metab Res"},{"issue":"8","key":"10.1016\/j.ctrv.2013.06.005_b0185","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.ejca.2006.02.004","article-title":"A functional polymorphism in the promoter region of leptin gene increases susceptibility for non-small cell lung cancer","volume":"42","author":"Ribeiro","year":"2006","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ctrv.2013.06.005_b0190","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00432-011-1098-6","article-title":"The role of leptin receptor gene polymorphisms in determining the susceptibility and prognosis of NSCLC in Chinese patients","volume":"138","author":"Li","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2013.06.005_b0195","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000177952","article-title":"Elevated serum leptin levels: a risk factor for non-small-cell lung cancer?","volume":"76","author":"Terzidis","year":"2009","journal-title":"Oncology"},{"issue":"8","key":"10.1016\/j.ctrv.2013.06.005_b0200","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3727\/000000006783980900","article-title":"IL-2, TNF-alpha, and leptin: local versus systemic concentrations in NSCLC patients","volume":"16","author":"Carpagnano","year":"2007","journal-title":"Oncol Res"},{"issue":"5383","key":"10.1016\/j.ctrv.2013.06.005_b0205","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1126\/science.281.5383.1683","article-title":"Biological action of leptin as an angiogenic factor","volume":"281","author":"Sierra-Honigmann","year":"1998","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ctrv.2013.06.005_b0210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/canjclin.56.2.69","article-title":"Chronic inflammation: a common and important factor in the pathogenesis of neoplasia","volume":"56","author":"Schottenfeld","year":"2006","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.ctrv.2013.06.005_b0215","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01243894-200605000-00003","article-title":"Chemokines in the biology of lung cancer","volume":"1","author":"Arenberg","year":"2006","journal-title":"J Thorac Oncol"},{"issue":"3B","key":"10.1016\/j.ctrv.2013.06.005_b0220","first-page":"2027","article-title":"Prognostic significance of T helper 1 and 2 and T cytotoxic 1 and 2 cells in patients with non-small cell lung cancer","volume":"25","author":"Ito","year":"2005","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.ctrv.2013.06.005_b0225","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1210\/en.2004-0782","article-title":"Differential regulation of leptin synthesis in rats during short-term hypoxia and short-term carbon monoxide inhalation","volume":"146","author":"Meissner","year":"2005","journal-title":"Endocrinology"},{"issue":"37","key":"10.1016\/j.ctrv.2013.06.005_b0230","doi-asserted-by":"crossref","first-page":"34601","DOI":"10.1074\/jbc.M205172200","article-title":"J. transcriptional activation of the human leptin gene in response to hypoxia. Involvement of hypoxia-inducible factor 1","volume":"277","author":"Ambrosini","year":"2002","journal-title":"J Biol Chem"},{"issue":"Suppl.","key":"10.1016\/j.ctrv.2013.06.005_b0235","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1016\/S0012-3692(15)31581-6","article-title":"Acute exposure to cigarette smoke as a cause of hypoxia","volume":"59","author":"Anderson","year":"1971","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ctrv.2013.06.005_b0240","first-page":"6","article-title":"Influence of cigarette smoking on the hypoxic pulmonary vasoconstriction in isolated rat lungs\u2013the role of prostaglandins and leukotrienes","volume":"12","author":"Yang","year":"1992","journal-title":"J Tongji Med Univ"},{"issue":"2","key":"10.1016\/j.ctrv.2013.06.005_b0245","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3346\/jkms.2012.27.2.128","article-title":"Pathophysiological role of hormones and cytokines in cancer cachexia","volume":"27","author":"Kim","year":"2012","journal-title":"J Korean Med Sci"},{"issue":"5","key":"10.1016\/j.ctrv.2013.06.005_b0250","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2013.06.005_b0255","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern cooperative oncology group","volume":"69","author":"Dewys","year":"1980","journal-title":"Am J Med"},{"issue":"7117","key":"10.1016\/j.ctrv.2013.06.005_b0260","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/bmj.315.7117.1219","article-title":"ABC of palliative care. Anorexia, cachexia, and nutrition","volume":"315","author":"Bruera","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ctrv.2013.06.005_b0265","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/SPC.0b013e3283311d09","article-title":"The role of cytokines in cancer cachexia","volume":"3","author":"Argil\u00e9s","year":"2009","journal-title":"Curr Opin Support Palliat Care"},{"issue":"3","key":"10.1016\/j.ctrv.2013.06.005_b0270","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/cs0930273","article-title":"Plasma concentration of total leptin and human lung-cancer-associated cachexia","volume":"93","author":"Simons","year":"1997","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"10.1016\/j.ctrv.2013.06.005_b0275","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/cyto.2002.1051","article-title":"Leptin role in advanced lung cancer. A mediator of the acute phase response or a marker of the status of nutrition?","volume":"19","author":"Alem\u00e1n","year":"2002","journal-title":"Cytokine"},{"issue":"2\u20133","key":"10.1016\/j.ctrv.2013.06.005_b0280","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cyto.2004.03.017","article-title":"Adiponectin and the systemic inflammatory response in weight-losing patients with non-small cell lung cancer","volume":"27","author":"Jamieson","year":"2004","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.ctrv.2013.06.005_b0285","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1385\/MO:22:4:353","article-title":"Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer","volume":"22","author":"Tas","year":"2005","journal-title":"Med Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2013.06.005_b0290","first-page":"500","article-title":"Leptin serum levels in cachectic and non-cachectic lung cancer patients","volume":"77","author":"Wery\u0144ska","year":"2009","journal-title":"Pneumonol Alergol Pol"},{"issue":"3","key":"10.1016\/j.ctrv.2013.06.005_b0295","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2310\/JIM.0b013e3181cf91ca","article-title":"Adipokines in patients with cancer anorexia and cachexia","volume":"58","author":"Smiechowska","year":"2010","journal-title":"J Investig Med"},{"issue":"3","key":"10.1016\/j.ctrv.2013.06.005_b0300","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00408-011-9364-6","article-title":"Adipokines and Systemic Inflammation in Weight-Losing Lung Cancer Patients","volume":"190","author":"Gulen","year":"2012","journal-title":"Lung"},{"issue":"7","key":"10.1016\/j.ctrv.2013.06.005_b0305","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s001090100234","article-title":"Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites","volume":"79","author":"Mantovani","year":"2001","journal-title":"J Mol Med (Berl)"},{"issue":"3","key":"10.1016\/j.ctrv.2013.06.005_b0310","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.lungcan.2008.01.018","article-title":"The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC)","volume":"61","author":"Karapanagiotou","year":"2008","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.ctrv.2013.06.005_b0315","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.clnu.2009.08.013","article-title":"The relationship between the insulin-like growth factor-1 axis, weight loss, an inflammation-based score and survival in patients with inoperable non-small cell lung cancer","volume":"29","author":"Meek","year":"2010","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.ctrv.2013.06.005_b0320","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.lungcan.2011.05.009","article-title":"Mini nutritional assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: interrelations and associations with prognosis","volume":"74","author":"Gioulbasanis","year":"2011","journal-title":"Lung Cancer"},{"issue":"12","key":"10.1016\/j.ctrv.2013.06.005_b0325","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s00432-011-1054-5","article-title":"Expression and clinical significance of leptin, the functional receptor of leptin (OB-Rb) and HER-2 in non-small-cell lung cancer: a retrospective analysis","volume":"137","author":"Xu","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2013.06.005_b0330","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/bbrc.1996.0587","article-title":"CDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose most abundant gene transcript 1)","volume":"221","author":"Maeda","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"issue":"18","key":"10.1016\/j.ctrv.2013.06.005_b0335","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.1074\/jbc.271.18.10697","article-title":"AdipoQ is a novel adipose-specific gene dysregulated in obesity","volume":"271","author":"Hu","year":"1996","journal-title":"J Biol Chem"},{"issue":"6941","key":"10.1016\/j.ctrv.2013.06.005_b0340","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","article-title":"Cloning of adiponectin receptors that mediate antidiabetic metabolic effects","volume":"423","author":"Yamauchi","year":"2003","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ctrv.2013.06.005_b0345","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2005-0005","article-title":"Adiponectin and adiponectin receptors","volume":"26","author":"Kadowaki","year":"2005","journal-title":"Endocr Rev"},{"issue":"28","key":"10.1016\/j.ctrv.2013.06.005_b0350","doi-asserted-by":"crossref","first-page":"10308","DOI":"10.1073\/pnas.0403382101","article-title":"T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30\/adiponectin","volume":"101","author":"Hug","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.ctrv.2013.06.005_b0355","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.beem.2005.07.008","article-title":"Adipocytokines: leptin\u2013the classical, resistin\u2013the controversical, adiponectin\u2013the promising, and more to come","volume":"19","author":"Koerner","year":"2005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ctrv.2013.06.005_b0360","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1463-1326.2005.00510.x","article-title":"Adiponectin\u2013a key adipokine in the metabolic syndrome","volume":"8","author":"Whitehead","year":"2006","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.ctrv.2013.06.005_b0365","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosissup.2005.02.003","article-title":"Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease","volume":"6","author":"Matsuzawa","year":"2005","journal-title":"Atheroscler Suppl"},{"issue":"6","key":"10.1016\/j.ctrv.2013.06.005_b0370","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000331462","article-title":"Cross-sectional association between blood pressure, in vivo insulin sensitivity and adiponectin in overweight adolescents","volume":"76","author":"De Las Heras","year":"2011","journal-title":"Horm Res Paediatr"},{"issue":"9","key":"10.1016\/j.ctrv.2013.06.005_b0375","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6603051","article-title":"Adiponectin and cancer: a systematic review","volume":"94","author":"Kelesidis","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2013.06.005_b0380","doi-asserted-by":"crossref","first-page":"18341","DOI":"10.1074\/jbc.M501149200","article-title":"Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner","volume":"280","author":"Wang","year":"2005","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.ctrv.2013.06.005_b0385","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1073\/pnas.0308671100","article-title":"Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis","volume":"101","author":"Br\u00e5kenhielm","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ctrv.2013.06.005_b0390","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1161\/01.CIR.100.25.2473","article-title":"Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin","volume":"100","author":"Ouchi","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ctrv.2013.06.005_b0395","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood.V96.5.1723","article-title":"Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages","volume":"96","author":"Yokota","year":"2000","journal-title":"Blood"},{"issue":"3\u20134","key":"10.1016\/j.ctrv.2013.06.005_b0400","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000127424","article-title":"Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies","volume":"73","author":"Petridou","year":"2007","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.ctrv.2013.06.005_b0405","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2337\/diabetes.51.2.536","article-title":"Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population","volume":"51","author":"Hara","year":"2002","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.ctrv.2013.06.005_b0410","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1158\/0008-5472.CAN-08-0533","article-title":"Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk","volume":"68","author":"Kaklamani","year":"2008","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.ctrv.2013.06.005_b0415","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/pcan.2010.27","article-title":"Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans","volume":"13","author":"Beebe-Dimmer","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"13","key":"10.1016\/j.ctrv.2013.06.005_b0420","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/jama.300.13.1523","article-title":"Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk","volume":"300","author":"Kaklamani","year":"2008","journal-title":"Source JAMA"},{"issue":"3","key":"10.1016\/j.ctrv.2013.06.005_b0425","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1139\/o11-005","article-title":"The role of adiponectin (ADIPOQ) gene polymorphisms in the susceptibility and prognosis of non-small cell lung cancer","volume":"89","author":"Cui","year":"2011","journal-title":"Biochem Cell Biol"},{"issue":"12","key":"10.1016\/j.ctrv.2013.06.005_b0430","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1200\/JCO.2006.07.2777","article-title":"Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes","volume":"25","author":"Govindarajan","year":"2007","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2013.06.005_b0435","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2337\/dc10-1067","article-title":"Cohort study of pioglitazone and cancer incidence in patients with diabetes","volume":"34","author":"Ferrara","year":"2011","journal-title":"Diabetes Care"},{"issue":"15","key":"10.1016\/j.ctrv.2013.06.005_b0440","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1093\/emboj\/19.15.4046","article-title":"FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family","volume":"19","author":"Holcomb","year":"2000","journal-title":"EMBO J"},{"issue":"4","key":"10.1016\/j.ctrv.2013.06.005_b0445","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2796.2004.01306.x","article-title":"The current biology of resistin","volume":"255","author":"Steppan","year":"2004","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.ctrv.2013.06.005_b0450","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0006-291X(02)02841-3","article-title":"Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators","volume":"300","author":"Patel","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"6818","key":"10.1016\/j.ctrv.2013.06.005_b0455","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ctrv.2013.06.005_b0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/oby.2002.1","article-title":"Resistin gene expression in human adipocytes is not related to insulin resistance","volume":"10","author":"Janke","year":"2002","journal-title":"Obes Res"},{"issue":"2","key":"10.1016\/j.ctrv.2013.06.005_b0465","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clim.2009.07.013","article-title":"The role of resistin as a regulator of inflammation: Implications for various human pathologies","volume":"133","author":"Filkov\u00e1","year":"2009","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.ctrv.2013.06.005_b0470","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3346\/jkms.2007.22.1.117","article-title":"Relationship of serum adiponectin and resistin levels with breast cancer risk","volume":"22","author":"Kang","year":"2007","journal-title":"J Korean Med Sci"},{"issue":"3","key":"10.1016\/j.ctrv.2013.06.005_b0475","first-page":"241","article-title":"Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristics","volume":"28","author":"Pamuk","year":"2006","journal-title":"Exp Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2013.06.005_b0480","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cardiores.2006.01.015","article-title":"Adipokine resistin promotes in vitro angiogenesis of human endothelial cells","volume":"70","author":"Mu","year":"2006","journal-title":"Cardiovasc Res"},{"issue":"10","key":"10.1016\/j.ctrv.2013.06.005_b0485","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1210\/en.2007-0175","article-title":"Chemerin is a novel adipokine associated with obesity and metabolic syndrome","volume":"148","author":"Bozaoglu","year":"2007","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.ctrv.2013.06.005_b0490","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cmet.2007.08.010","article-title":"The rapidly expanding family of adipokines","volume":"6","author":"MacDougald","year":"2007","journal-title":"Cell Metab"},{"issue":"5\u20136","key":"10.1016\/j.ctrv.2013.06.005_b0495","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cytogfr.2011.11.004","article-title":"Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism","volume":"22","author":"Bondue","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"issue":"11","key":"10.1016\/j.ctrv.2013.06.005_b0500","first-page":"1174","article-title":"Detection of chemerin and it\u2019s clinical significance in peripheral blood of patients with lung cancer","volume":"12","author":"Qu","year":"2009","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"1","key":"10.1016\/j.ctrv.2013.06.005_b0505","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/CS20070226","article-title":"Visfatin\/PBEF\/Nampt: structure, regulation and potential function of a novel adipokine","volume":"115","author":"Sommer","year":"2008","journal-title":"Clin Sci (Lond)"},{"issue":"5708","key":"10.1016\/j.ctrv.2013.06.005_b0510","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: a protein secreted by visceral fat that mimics the effects of insulin","volume":"307","author":"Fukuhara","year":"2005","journal-title":"Science"},{"issue":"5850","key":"10.1016\/j.ctrv.2013.06.005_b0515","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1126\/science.318.5850.565b","volume":"318","author":"Fukuhara","year":"2007","journal-title":"Retraction Sci"},{"issue":"3","key":"10.1016\/j.ctrv.2013.06.005_b0520","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.178.3.1748","article-title":"Visfatin, an adipocytokine with proinflammatory and immunomodulating properties","volume":"178","author":"Moschen","year":"2007","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.ctrv.2013.06.005_b0525","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4161\/cbt.10.2.12581","article-title":"Nampt\/PBEF\/visfatin and cancer","volume":"10","author":"Bi","year":"2010","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"10.1016\/j.ctrv.2013.06.005_b0530","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/JTO.0b013e318233d686","article-title":"Nicotinamide phosphoribosyltransferase: a potent therapeutic target in non-small cell lung cancer with epidermal growth factor receptor-gene mutation","volume":"7","author":"Okumura","year":"2012","journal-title":"J Thorac Oncol"},{"issue":"1 Suppl.","key":"10.1016\/j.ctrv.2013.06.005_b0535","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/1097-0142(19850101)55:1+<225::AID-CNCR2820551304>3.0.CO;2-7","article-title":"Metabolic abnormalities in the cancer patient","volume":"55","author":"Heber","year":"1985","journal-title":"Cancer"},{"issue":"7\u20138","key":"10.1016\/j.ctrv.2013.06.005_b0540","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0899-9007(01)00561-5","article-title":"Insulin resistance in patients with cancer: relationships with tumor site, tumor stage, body-weight loss, acute phase response, and energy expenditure","volume":"17","author":"Yoshikawa","year":"2001","journal-title":"Nutrition"},{"issue":"2","key":"10.1016\/j.ctrv.2013.06.005_b0545","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/ajcn\/71.2.583","article-title":"Weight loss and elevated gluconeogenesis from alanine in lung cancer patients","volume":"71","author":"Leij-Halfwerk","year":"2000","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1016\/j.ctrv.2013.06.005_b0550","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/ijc.27719","article-title":"Obesity and incidence of lung cancer: a meta-analysis","volume":"132","author":"Yang","year":"2013","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.ctrv.2013.06.005_b0555","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1210\/en.2008-1706","article-title":"Pegylated leptin antagonist is a potent orexigenic agent: preparation and mechanism of activity","volume":"150","author":"Elinav","year":"2009","journal-title":"Endocrinology"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030573721300128X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030573721300128X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T06:19:33Z","timestamp":1688365173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030573721300128X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S030573721300128X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2013.06.005","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hormones of adipose tissue and their biologic role in lung cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2013.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}